Reposted by Haan
The newly launched cancer start-up Dispatch Biotherapeutics has an ambitious goal: to treat all solid-tumor cancers using immunotherapies, starting with chimeric antigen receptor T-cell therapy, or CAR-T. cen.acs.org/pharmaceutic... #chemsky 🧪
cen.acs.org
Facebook cofounder backs cancer start-up that aims to treat all solid tumors
With $216 million, Dispatch Biotherapeutics is developing targeted immunotherapies